Grid Therapeutics
Latest round
- Series A
Last raised
- Sep 2017
Total raised
- Undisclosed
Investors
- 2
About Grid Therapeutics
Grid Therapeutics LLC, founded in 2014, is based in Durham, US and specializes in oncology treatments.Grid Therapeutics specializes in innovative cancer therapies by leveraging the human immune system to develop novel tumor-specific therapeutic antibodies. Their primary product, GT103, targets advanced stage non-small cell lung cancer (NSCLC) and is developed using single human B cells, enabling rapid generation of antibodies tailored to specific tumor antigens.Grid Therapeutics operates within a collaborative framework that includes partnerships with pharmaceutical companies and research organizations to enhance its clinical trials and product development. Revenue generation derives from licensing agreements, research collaborations, and milestone payments associated with their product candidates, particularly GT103.Grid Therapeutics aims to expand its product offerings and enter new markets.5 mn, the company plans to invest in further developing GT103 and exploring additional therapeutic candidates. Future geographic expansion may include targeting markets in Europe and Asia by 2022, contingent upon regulatory approvals and clinical trial progress.
Who invested in Grid Therapeutics
2 investors across 1 round
See all investors in Grid Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 14, 2017
Amount
Undisclosed
Investors
Questions about Grid Therapeutics
Who invested in Grid Therapeutics?
Grid Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Grid Therapeutics raised?
Grid Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Grid Therapeutics last raise money?
Grid Therapeutics's most recent round on record is a Series A, in Sep 2017.
What does Grid Therapeutics do?
Grid Therapeutics LLC, founded in 2014, is based in Durham, US and specializes in oncology treatments.
Where is Grid Therapeutics headquartered?
Grid Therapeutics is headquartered in Durham, US.
Which VCs invest in companies like Grid Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Grid Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Grid Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.